Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2010
11/09/2010US7829275 Target analyte supported on conductive support containing a nanoparticle comprising a photoelectrochemically active group, exposing the active group with light to generate photoelectric current, measuring the current
11/09/2010CA2474563C Methods of inhibiting orthopoxvirus replication with nucleoside compounds
11/04/2010WO2010127210A1 Method of reducing intraocular pressure in humans
11/04/2010WO2010126435A1 Novel galactoside inhibitors of galectins
11/04/2010WO2010125200A1 Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral angents
11/04/2010WO2010106320A3 Isolation and purification of components of whey
11/04/2010WO2010002877A3 Bycyclic nucleosides and nucleotides as therapeutic agents
11/04/2010WO2009152095A3 Nucleoside cyclicphosphates
11/04/2010US20100280235 METHOD FOR PRODUCING 4'ETHYNYL d4T
11/04/2010US20100280234 Photocleavable Protecting Groups and Methods for Their Use
11/04/2010US20100279974 Nucleosides With Non-Natural Bases as Anti-Viral Agents
11/04/2010US20100279973 Synthesis of purine nucleosides
11/04/2010US20100279969 Azido purine nucleosides for treatment of viral infections
11/04/2010US20100279968 Mutagenic Nucleoside Analogs for the Treatment of Viral Disease
11/04/2010US20100279966 Compositions and methods for treating cancer
11/04/2010CA2762064A1 Method of reducing intraocular pressure in humans
11/03/2010EP1660511B1 Novel tricyclic nucleosides or nucleotides as therapeutic agents
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN101875680A Nucleoside compound, preparation method and application thereof
11/03/2010CN101875679A Antiparasitic compound and preparation method thereof
11/03/2010CN101096380B Method for purifying citicoline from biotransformation or multienzyme reaction liquid
11/02/2010US7825239 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one for prevention and treatment of viral infection
11/02/2010US7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
11/02/2010US7825237 Oligonucleotides and analogs labeled with energy transfer dyes
11/02/2010US7825103 5'-O-triisopropylsilyl-2'-cyano-2'-deoxy-1- beta -D-arabinofuranosylcytosine; antitumor agents
11/02/2010US7824863 Nucleic acid labeling methods
11/02/2010US7824851 With purine or pyrimidine base; for use in combination with drugs that induce mutation in Flaviviridae at location other than mutation of nucleotide that results in change from serine to a different amino acid in highly conserved consensus sequence XRXSGXXXT of domain B of the RNA polymerase region
11/02/2010CA2341520C Energy transfer dyes
10/2010
10/28/2010WO2010121576A2 Novel 7-deazapurine nucleosides for therapeutic uses
10/28/2010WO2010121486A1 Prodrugs based on gemcitabine structure as well as synthetic method and application thereof
10/28/2010WO2009114814A3 Therapeutic substances that modulate genome methylation
10/28/2010US20100274000 Light-responsive artificial nucleotide having photo-crosslinking ability
10/28/2010US20100273742 Pharmacologically Active Agents Containing Esterified Phosphonates and Methods for Use Thereof
10/28/2010US20100272791 Composition having effect on treatment and prevention of dry eye syndrome
10/28/2010CA2759474A1 Prodrugs based on gemcitabine structure and synthetic methods and applications thereof
10/28/2010CA2759131A1 Novel 7-deazapurine nucleosides for therapeutic uses
10/27/2010CN101874036A Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat
10/27/2010CN101870717A Oligonucleotide direct condensation method reagent and application thereof
10/26/2010US7820811 [(3aR,4R,6R,6aR)-6-(6-amino-2-methoxy-9H-purin-9yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methanol; improved oral absorption
10/26/2010US7820637 Use of 5′-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection
10/26/2010US7820631 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV)
10/26/2010US7820391 Baseless nucleotide analogues and uses thereof
10/26/2010US7820037 Desulfurizing agent manufacturing method and hydrocarbon desulfurization method
10/26/2010CA2327494C Novel crystalline forms of an antiviral benzimidazole compound
10/21/2010US20100267937 Cyanine Dye Labelling Reagents
10/20/2010EP2241571A1 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same
10/20/2010EP2241556A1 Method for the preparation of capecitabine and intermediates used in said method
10/20/2010CN101863943A Crystallizing method of 5'-guanosine-monophosphate disodium salt
10/20/2010CN101863942A Method for preparing isoprinosine and oral preparation thereof
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/19/2010US7816513 subjecting an inosine derivative to dithiocarbonylation and carrying out radical reduction of the obtained compound; produces compounds useful as anti-AIDS drugs on industrial scale
10/19/2010US7816501 Peptide nucleic acids with donor and acceptor moieties for detecting or identifying the presence, absence or quantity of a target sequence of a target molecule such as via fluorescence resonance energy transfer
10/19/2010US7816333 nucleosides such as 3',5'-di-O-Benzyl-2'-O,4'-C-ethylene-4-N-benzoylcytidine for treatment of pain, psoriasis, inflammatory disorders, infectious skin disease, skin cancer, Lyme disease, influenza virus, cytomegalovirus, herpes virus, herpes simplex virus, papilloma virus, Epstein Barr virus or HIV
10/19/2010CA2439319C Process for the preparation of (e)-5-(2-bromovinyl)-2'-deoxyuridine
10/19/2010CA2379988C Enzyme catalyzed therapeutic activation
10/14/2010WO2010118006A1 (2 ' -deoxy-ribofuranosyl) -1,3,4, 7-tetrahydro- (1,3) iazepin-2-0ne derivatives for treating cancer
10/14/2010WO2010065787A3 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
10/14/2010WO2010062404A3 N-fmoc nucleosides and phosphoramidites, and oligonucleotide synthesis
10/14/2010US20100261668 Inhibitors of s-adenosyl-l-methionine decarboxylase
10/14/2010US20100261667 3-ß-D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF
10/14/2010US20100261664 Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
10/14/2010CA2757743A1 (2'-deoxy-ribofuranosyl)-1,3,4,7-tetrahydro-(1,3) diazepin-2-0ne derivatives for treating cancer
10/13/2010EP1458734B1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer
10/13/2010CN101857623A Method for extracting GP4G from organism
10/13/2010CN101857622A Adenosine derivative, and preparation method and application thereof
10/07/2010WO2010113937A1 Process for producing nucleoside
10/07/2010US20100256087 Compositions for the treatment or prophylaxis of viral infections
10/07/2010US20100256086 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/07/2010US20100255464 Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis
10/06/2010EP2234490A2 Substituted 4-{3-ý6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl¨-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists
10/06/2010CN101855231A Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
10/06/2010CN101062928B Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/05/2010US7807807 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
10/05/2010US7807654 Compositions and methods for treatment of mitochondrial diseases
10/05/2010US7807653 Nucleotide mimics and their prodrugs
10/05/2010CA2530798C Synthesis and compositions of 2'-terminator nucleotides
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
09/2010
09/30/2010WO2010110775A1 Reagents for reversibly terminating primer extension
09/30/2010WO2010090969A4 Tetrahydropyran nucleic acid analogs
09/30/2010WO2010065671A3 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/30/2010WO2010065662A3 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
09/30/2010US20100249395 Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein
09/30/2010US20100249394 Processes for producing decitabine
09/30/2010US20100249393 Colorimetric-oxycarbonyl protecting groups for use in organic syntheses
09/30/2010US20100249373 Screening methods
09/30/2010US20100249211 N-Substituted-Aminomethylene Bridged Bicyclic Nucleic Acid Analogs
09/30/2010US20100249056 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates
09/30/2010US20100249055 Clofarabine phospholipid derivatives
09/30/2010US20100249054 Purine nucleoside derivative modified in 8-position and medical use thereof
09/30/2010US20100249053 Method for inducing hepatocyte proliferation and uses thereof
09/29/2010EP2231690A2 Clofarabine dietherphospholipid derivatives
09/29/2010EP2231689A1 Novel cytostatic 7-deazapurine nucleosides
09/29/2010EP2231688A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
09/29/2010EP2231687A2 Novel derivatives of acyl cyanopyrrolidines
09/29/2010EP2231132A2 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
09/29/2010EP1984381B1 6-modified bicyclic nucleic acid analogs
09/29/2010CN1860364B Fluorescently tagged ligands
09/29/2010CN101848710A Anthelmintic combination
09/29/2010CN101845072A 2'-deoxy-2', 2'-difluoro-3', 5'-double (substituted benzoate) cytosine and preparation method thereof
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 201